Quote:think tecentriq was pulled for breast cancer (after our trials) for being ineffective?
I guess because Leron was not part of the cocktail outside our trials. Evidently Leron did the trick.
How hot were the tumors in the tecentriq trial? They were combining it with nab-paclitaxel which is not an immune booster. Using a PD-L1 inhibitor in an environment with a dysregulated immune system exhibiting lower tumor killing macrophages and it will not have great effect. Add leronlimab that boosts those killer macrophages and downregulates at least an additional six immune checkpoint proteins then you really have something.